Combined prognostic value of the cancer stem cell markers CD47 and CD133 in esophageal squamous cell carcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combined prognostic value of the cancer stem cell markers CD47 and CD133 in esophageal squamous cell carcinoma
Authors
Keywords
-
Journal
Cancer Medicine
Volume 8, Issue 3, Pages 1315-1325
Publisher
Wiley
Online
2019-02-11
DOI
10.1002/cam4.1894
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer immunotherapy targeting the CD47/SIRPα axis
- (2017) Kipp Weiskopf EUROPEAN JOURNAL OF CANCER
- MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF
- (2017) B Li et al. ONCOGENE
- Targeting CD47 Enhances the Efficacy of Anti-PD-1 and CTLA-4 in an Esophageal Squamous Cell Cancer Preclinical Model
- (2017) Hua Tao et al. ONCOLOGY RESEARCH
- Replication Study: The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
- (2017) Stephen K Horrigan et al. eLife
- Anti-CD47 Antibody As a Targeted Therapeutic Agent for Human Lung Cancer and Cancer Stem Cells
- (2017) Liang Liu et al. Frontiers in Immunology
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The CD47 “don't eat me signal” is highly expressed in human ovarian cancer
- (2016) R.M. Brightwell et al. GYNECOLOGIC ONCOLOGY
- CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer
- (2016) Kipp Weiskopf et al. JOURNAL OF CLINICAL INVESTIGATION
- Expression of the potential cancer stem cell markers CD133 and CD44 in medullary thyroid carcinoma: A ten-year follow-up and prognostic analysis
- (2016) Yalan Bi et al. JOURNAL OF SURGICAL ONCOLOGY
- Durable antitumor responses to CD47 blockade require adaptive immune stimulation
- (2016) Jonathan T. Sockolosky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer
- (2016) Sukhbir Kaur et al. Oncotarget
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis
- (2015) G. Bertolini et al. CANCER RESEARCH
- Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms
- (2015) M. Cioffi et al. CLINICAL CANCER RESEARCH
- RASSF8 downregulation promotes lymphangiogenesis and metastasis in esophageal squamous cell carcinoma
- (2015) Lan Zhang et al. Oncotarget
- Blockade of CD47-mediated cathepsin S/protease-activated receptor 2 signaling provides a therapeutic target for hepatocellular carcinoma
- (2014) Terence Kin-Wah Lee et al. HEPATOLOGY
- Esophageal Carcinoma
- (2014) Anil K. Rustgi et al. NEW ENGLAND JOURNAL OF MEDICINE
- A CD90+ Tumor-Initiating Cell Population with an Aggressive Signature and Metastatic Capacity in Esophageal Cancer
- (2013) K. H. Tang et al. CANCER RESEARCH
- Myeloid-Derived Suppressor Cells Enhance Stemness of Cancer Cells by Inducing MicroRNA101 and Suppressing the Corepressor CtBP2
- (2013) Tracy X. Cui et al. IMMUNITY
- A Cancer Stem Cell Model for Studying Brain Metastases From Primary Lung Cancer
- (2013) Sara M. Nolte et al. JNCI-Journal of the National Cancer Institute
- Oesophageal carcinoma
- (2013) Arjun Pennathur et al. LANCET
- Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma
- (2012) D. Hang et al. DISEASES OF THE ESOPHAGUS
- An in situ molecular signature to predict early recurrence in hepatitis B virus-related hepatocellular carcinoma
- (2012) Jing Xu et al. JOURNAL OF HEPATOLOGY
- CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma
- (2012) SHIGEMASA SUZUKI et al. ONCOLOGY REPORTS
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
- (2012) S. B. Willingham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nodal/Activin Signaling Drives Self-Renewal and Tumorigenicity of Pancreatic Cancer Stem Cells and Provides a Target for Combined Drug Therapy
- (2011) Enza Lonardo et al. Cell Stem Cell
- The cancer stem cell: premises, promises and challenges
- (2011) Hans Clevers NATURE MEDICINE
- Tumor Initiating Cells in Esophageal Squamous Cell Carcinomas Express High Levels of CD44
- (2011) Jiang-Sha Zhao et al. PLoS One
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now